![women women](https://surgicaltechie.com/wp-content/uploads/2019/03/bmi.jpg)
The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years. The USPSTF recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.Ĭolorectal Cancer: Screening: adults aged 45 to 49 years The USPSTF recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection. See the Clinical Considerations section for the relative benefits and harms of alternative screening strategies for women 21 years or older.Ĭhlamydia and Gonorrhea: Screening: sexually active women, including pregnant persons
![women women](https://i.pinimg.com/736x/8f/23/bc/8f23bc62c6d420c191b0ed5be7143e67.jpg)
For women aged 30 to 65 years, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting). The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. The USPSTF recommends providing interventions during pregnancy and after birth to support breastfeeding.Ĭervical Cancer: Screening: women aged 21 to 65 years †īreastfeeding: Primary Care Interventions: pregnant women, new mothers, and their children The USPSTF recommends biennial screening mammography for women aged 50 to 74 years. The USPSTF recommends that clinicians offer to prescribe risk-reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, to women who are at increased risk for breast cancer and at low risk for adverse medication effects.īreast Cancer: Screening: women aged 50 to 74 years Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.īreast Cancer: Medication Use to Reduce Risk: women at increased risk for breast cancer aged 35 years or older The USPSTF recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. The USPSTF recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.īRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing: women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or an ancestry associated with brca1/2 gene mutation See the Practice Considerations section for information on high risk and aspirin dose.Īsymptomatic Bacteriuria in Adults: Screening: pregnant persons The USPSTF recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia. The USPSTF recommends screening for anxiety in children and adolescents aged 8 to 18 years.Īspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication: pregnant persons at high risk for preeclampsia The USPSTF recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.Īnxiety in Children and Adolescents: Screening: children and adolescents aged 8 to 18 years The USPSTF recommends 1-time screening for abdominal aortic aneurysm (AAA) with ultrasonography in men aged 65 to 75 years who have ever smoked.Īnxiety Disorders in Adults: Screening: adults 64 years or younger, including pregnant and postpartum persons Print PDF TopicĪbdominal Aortic Aneurysm: Screening: men aged 65 to 75 years who have ever smoked
![women women](https://image.slidesharecdn.com/weightchartforwomen-averageofbmichartforwomenbyage-180110144745/95/weight-chart-for-women-average-of-bmi-chart-for-women-by-age-8-638.jpg)
![women women](https://feeds.abplive.com/onecms/images/uploaded-images/2024/03/08/320533b76e8830673bfba9aed89aa7731709838488382410_original.jpg)
These preventive services have a high or moderate net benefit for patients. A listing of all the Recommendations with a grade of either A or B.Ī and B grade recommendations are services that the Task Force most highly recommends implementing for preventive care and that are also relevant for implementing the Affordable Care Act.